← Eichor
Condition: Mucosal Neoplasm Of Oral Cavity Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Mucosal Neoplasm Of Oral Cavity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Biospecimen Procurement for Head and Neck Disorders
Phase N/A · 9 location(s) · National Cancer Institute (NCI) · NCT03429036Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT03889899Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients
NA · 1 location(s) · Mucosa Innovations, S.L. · NCT05635929Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT04534127The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorde
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT06535867Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cance
Phase 2/Phase 3 · 107 location(s) · NRG Oncology · NCT04333537Topical Imiquimod Treatment of Oral Dysplasia
Phase 1/Phase 2 · 1 location(s) · University of Southern California · NCT07210775
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.